Cargando…

Chronic Kidney Disease: Early Detection, Mechanisms, and Therapeutic Implications

Detalles Bibliográficos
Autores principales:	Delrue, Charlotte, Speeckaert, Marijn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607845/ https://www.ncbi.nlm.nih.gov/pubmed/37888058 http://dx.doi.org/10.3390/jpm13101447

Ejemplares similares

Vitamin D and Vitamin D-Binding Protein in Health and Disease
por: Delrue, Charlotte, et al.
Publicado: (2023)

Vitamin D and Vitamin D Binding Protein in Health and Disease 2.0
por: Delrue, Charlotte, et al.
Publicado: (2023)

Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside?
por: Delrue, Charlotte, et al.
Publicado: (2023)

The Potential Applications of Raman Spectroscopy in Kidney Diseases
por: Delrue, Charlotte, et al.
Publicado: (2022)

The Potential Use of Near- and Mid-Infrared Spectroscopy in Kidney Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases
por: Thielemans, Raïsa, et al.
Publicado: (2023)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Vitamin D Deficiency: An Underestimated Factor in Sepsis?
por: Delrue, Charlotte, et al.
Publicado: (2023)

The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach
por: Delrue, Charlotte, et al.
Publicado: (2022)

Unlocking the Diagnostic Potential of Saliva: A Comprehensive Review of Infrared Spectroscopy and Its Applications in Salivary Analysis
por: Delrue, Charlotte, et al.
Publicado: (2023)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2020)

Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2021)

Is VEGF a new therapeutic target for hypertension in chronic kidney disease?
por: Kim, Yon Su
Publicado: (2013)

Chronic Kidney Disease and Atherosclerosis: An Important Implication of Carotid Intima-Media Thickness
por: Ohtake, Takayasu, et al.
Publicado: (2021)

Signaling pathways of chronic kidney diseases, implications for therapeutics
por: Yuan, Qian, et al.
Publicado: (2022)

Exploring the possible therapeutic role of influenza vaccine in chronic kidney disease patients
por: Shrestha, Abhigan B., et al.
Publicado: (2023)

UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2020)

Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease
por: Tie, Yizhe, et al.
Publicado: (2023)

Gut Microbiome Profiling Uncovers a Lower Abundance of Butyricicoccus in Advanced Stages of Chronic Kidney Disease
por: Gryp, Tessa, et al.
Publicado: (2021)

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Hormone-Dependent Cancers: Molecular Mechanisms and Therapeutical Implications
por: Emons, Günter
Publicado: (2022)

Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

The biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Chronic Kidney Disease: Underlying Molecular Mechanisms—A Special Issue Overview
por: Belo, Luís, et al.
Publicado: (2023)

Future therapeutic implications of new molecular mechanism of colorectal cancer
por: Lu, Sen, et al.
Publicado: (2023)

Chronic kidney disease and the aging population
por: Tonelli, M., et al.
Publicado: (2014)

Chronic Kidney Disease and the Aging Population
por: Tonelli, M., et al.
Publicado: (2014)

Advances in Chronic Kidney Disease
por: Parrish, Alan R.
Publicado: (2016)

Chronic Kidney Disease is on the Rise
por: Haileamlak, Abraham
Publicado: (2018)

The gut–kidney connection in advanced chronic kidney disease
por: Inagi, Reiko
Publicado: (2015)

Preanalytical requirements of urinalysis
por: Delanghe, Joris, et al.
Publicado: (2014)

A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes
por: Speeckaert, Reinhart, et al.
Publicado: (2023)

Estimating tubular damage for predicting progression of chronic kidney disease—what are the implications for clinical practice and public health?
por: Nowak, Christoph, et al.
Publicado: (2021)

Can increased vigilance for chronic kidney disease in hospitalised patients decrease late referral and improve dialysis-free survival?
por: De Wilde, M., et al.
Publicado: (2018)

Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma
por: Speeckaert, Reinhart, et al.
Publicado: (2012)

Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications
por: Anders, Hans-Joachim, et al.
Publicado: (2023)

Prime time for chronic kidney disease
por: Weisman, David S., et al.
Publicado: (2023)

Diastolic dysfunction and chronic kidney disease
por: Cho, Goo-Yeong
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nf08nrgaab9694prl8d1boe2uj